CD8A and neoplasm: Tumor-infiltrating lymphocytes (TILs), including CD8+ cytotoxic T cells, Th1 cells, NK cells, dendritic cells (DCs), and B cells, are associated with improved prognosis and immune surveillance (Kumar et al., 2021; Yu et al., 2025).